Clinical, radiological and bacteriological features in geriatric tuberculosis (TB) patients (pts) - initial treatment and outcome Source: Eur Respir J 2002; 20: Suppl. 38, 363s Year: 2002
Clinical and bacteriological features of pneumonia associated with lung cancer (LC) Source: Eur Respir J 2003; 22: Suppl. 45, 253s Year: 2003
Miliary tuberculosis, clinical and outcome characeristics (about 61 cases) Source: Eur Respir J 2006; 28: Suppl. 50, 7s Year: 2006
Community acquired pneumonia (CAP) in children at the age over 3yrs - clinical, etiological and radiological features Source: Eur Respir J 2005; 26: Suppl. 49, 166s Year: 2005
Clinical, radiological, and bacteriological features of tuberculosis (TB) in teenagers' initial treatment and outcome Source: Eur Respir J 2005; 26: Suppl. 49, 648s Year: 2005
Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006
Differences in prognostic factors and outcome in community-acquired pneumonias (CAP) caused by viral pathogens (VP) or streptococcus pneumoniae (SP) Source: Eur Respir J 2001; 18: Suppl. 33, 542s Year: 2001
Association of CRP values with clinico-radiological appearance in adults with community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006
Videothoracoscopic (VTS) diagnostics of tuberculous (TB) spontaneous pneumothorax (SP) Source: Annual Congress 2009 - Pleural problems, congenital lesions and novel technical devices Year: 2009
Clinical and radiological (CR) features of tuberculosis formed as a result of immunosuppressive therapy (IT) Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012
Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP) Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005
Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trials Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014
Outcome of patients treated for culture-positive pulmonary tuberculosis (CPPTB) in Poland Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
Clinical, epidemiological and evolving profile of miliary tuberculosis: Study of 48 cases Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
The efficiency of the treatment of the patients with culture-positive pulmonary tuberculosis (CPPTB) in Gdannsk, Poland in 1995 and 2000 Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005
Clinical characteristics of 11 cases of pulmonary abscess in children Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
Interleukin-2 (IL-2) and interferon-γ(IF-γ) in idenitying severe community-acquired pneumonia (SCAP) clinical outcomes and complications Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Diagnostic aspects of chronic berylliosis (CB) and sarcoidosis (S) Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006
Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015
Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005